CVE-2016-8358
CVE-2016-8358 is a high-severity vulnerability in Smiths-medical Cadd-solis Medication Safety Software with a CVSS 3.x base score of 8.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-346.
Key facts
- Severity: High (CVSS 3.x base score 8.5)
- CVSS v2: 6.0
- EPSS exploit prediction: 0% (39th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-346
- Affected product: Smiths-medical Cadd-solis Medication Safety Software
- Published:
- Last modified:
Description
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.
Frequently asked questions
- What is CVE-2016-8358?
- An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.
- How severe is CVE-2016-8358?
- CVE-2016-8358 has a CVSS 3.x base score of 8.5, rated high severity. It is exploitable over network with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2016-8358 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (39th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2016-8358?
- CVE-2016-8358 primarily affects Smiths-medical Cadd-solis Medication Safety Software. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
- How do I fix CVE-2016-8358?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2016-8358 published?
- CVE-2016-8358 was published on 2017-02-13 and last updated on 2026-06-17.
References
Affected products (4)
- cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:1.0:*:*:*:*:*:*:*
- cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:2.0:*:*:*:*:*:*:*
- cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:3.0:*:*:*:*:*:*:*
- cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:3.1:*:*:*:*:*:*:*
More vulnerabilities in Smiths-medical Cadd-solis Medication Safety Software
- CVE-2016-8355 — Critical (CVSS 9.9): An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1.…
All CVEs affecting Smiths-medical Cadd-solis Medication Safety Software →
Other CWE-346 vulnerabilities
- CVE-2026-42901 — Critical (CVSS 10.0): Origin validation error in Microsoft Entra ID allows an unauthorized attacker to elevate privileges over a network.
- CVE-2026-6508 — Critical (CVSS 9.8): Origin Validation Error vulnerability in TUBITAK BILGEM Software Technologies Research Institute Liderahenk allows…
- CVE-2026-2790 — Critical (CVSS 9.8): Same-origin policy bypass in the Networking: JAR component. This vulnerability was fixed in Firefox 148, Firefox ESR…
- CVE-2022-50925 — Critical (CVSS 9.8): Prowise Reflect version 1.0.9 contains a remote keystroke injection vulnerability that allows attackers to send…
- CVE-2025-30466 — Critical (CVSS 9.8): This issue was addressed through improved state management. This issue is fixed in Safari 18.4, iOS 18.4 and iPadOS…
- CVE-2024-8487 — Critical (CVSS 9.8): A Cross-Origin Resource Sharing (CORS) vulnerability exists in modelscope/agentscope version v0.0.4. The CORS…